Stay updated with breaking news from Dougall Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments...
SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments to address the global myopia epidemic, today announced that the U.S. Food and Drug Administration (FDA) has...
/PRNewswire/ -- Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing transformative medicines for patients...
PBI-200 is being developed for the treatment of NRTK fusion-positive solid tumors, including primary and metastatic brain tumorsPBI-200 is presently being evaluated in a global Phase 1/2 multicenter clinical trialWALTHAM, Mass.--(BUSINESS WIRE)--#NRTK--Pyramid Biosciences, Inc., a clinical-stage biotechnology compan...
Collaboration will strengthen and amplify identification of patients with Neurotrophic Tyrosine Receptor Kinase (NTRK) fusion-positive solid tumors potentially...